Fetal outcome following inadvertant administration of long-acting DTRP6 GnRH microcapsules during pregnancy: A case report

Abraham Golan*, Raphael Ron-el, Arie Herman, Zvi Weinraub, Yigal Soffer, Eliahu Caspi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Early follkular use of long-acting analogues of gonadotrophin releasing hormone (GnRH) in IVF programmes has caused some concern with respect to its teratogenic potential. In the case reported here, an injection of DTRP6 GnRH micro-capsules was given in the 5th week of a spontaneous unsuspected pregnancy. No deleterious effect or teratogenesis of the embryo could be demonstrated at birth or 18 months later.

Original languageEnglish
Pages (from-to)123-124
Number of pages2
JournalHuman Reproduction
Volume5
Issue number1
DOIs
StatePublished - Jan 1990
Externally publishedYes

Keywords

  • DTRP6 GnRH microcapsules
  • Pregnancy

Fingerprint

Dive into the research topics of 'Fetal outcome following inadvertant administration of long-acting DTRP6 GnRH microcapsules during pregnancy: A case report'. Together they form a unique fingerprint.

Cite this